- The Washington Times - Monday, December 4, 2006

NEW YORK (AP) — Wall Street surged higher yesterday as investors put aside Pfizer Inc.’s decision to halt development of a key drug and focused instead on another series of takeover deals.

Pfizer shares fell by about 12 percent after the company stopped the development of the cholesterol drug torcetrapib because of deaths and cardiovascular problems among people taking the drug during clinical trials. The stock was also downgraded by several Wall Street analysts on concern that Pfizer’s revenue growth would weaken.

The news was offset by several merger announcements that reinforced the idea that companies are optimistic about the economy and therefore are willing to take some risks. Leading them was Bank of New York Corp.’s $16.5 billion deal to buy rival Mellon Financial Corp. to create an asset management powerhouse.

“Trading activity is being driven by the large amount of merger and acquisition announcements, specifically in the banking, semiconductor and hotel sectors of the market,” said Michael Sheldon, chief market strategist at Spencer Clarke LLC. “Many investors remain concerned about the economy, but are optimistic that a soft land lies ahead for U.S. financial markets.”

He said a Labor Department report Friday on November employment will add “fuel to the fire” if it is weaker than expected, or provide relief after a string of sluggish economic reports. Today, the Commerce Department issues data on factory orders for October, and the Institute for Supply Management releases its services sector business index.

The Dow Jones Industrial Average rose 89.72, or 0.74 percent, to 12,283.85.

Broader stock indicators were also higher. The Standard & Poor’s 500 Index was up 12.41, or 0.89 percent, at 1,409.12, and the Nasdaq Composite Index added 35.18, or 1.46 percent, to 2,448.39.

Stocks had stumbled Friday after a manufacturing survey unexpectedly contracted in November, pushing the major indexes to a loss for the week. However, major indexes are still poised to finish the year with double-digit gains. The Dow so far this year is up 14.61 percent, the S&P; 500 has gained 12.88 percent, and the Nasdaq has risen 11.02 percent.

“We really need somewhat of a pullback to keep us from using up all this fuel,” said Al Goldman, chief market strategist with A.G. Edwards & Sons. “But, overall, I’m still optimistic with a level of caution after the party we’ve already had.”

Bonds were little changed, with the yield on the benchmark 10-year Treasury note flat at 4.43 percent from late Friday. The dollar was mixed against other major currencies, while gold prices fell.

Oil prices reversed some of their increases last week but were expected to move higher because of fears that the Organization of Petroleum Exporting Countries would impose production cuts.

A barrel of light, sweet crude fell 99 cents to $62.44 on the New York Mercantile Exchange.

Drug makers were in focus after Pfizer pulled its cholesterol drug because of concern that it could cause deadly side effects. Shares of the Dow component fell $2.96, or 10.6 percent, to $24.90.

Rivals Merck & Co. and Schering-Plough Corp. were mixed, although their cholesterol drug was seen thriving with competition eliminated. The two companies partner to make Zeita and Vytorin. Merck fell 36 cents to $44.70, while Schering-Plough added 80 cents, or 3.7 percent, to $22.73.

Bank of New York’s all-stock deal to buy Mellon will create the world’s leading asset servicer with $16.6 trillion in assets under custody. It also ranks among the top 10 global money managers with more than $1.1 trillion in assets under management.

Shares of Bank of New York leapt $4.27, or 12 percent, to $39.75. Mellon rose $2.73, or 6.8 percent, to $42.78.

LSI Logic Corp. said it will buy rival chip and storage systems maker Agere Systems Inc. for $4 billion in stock.

The purchase price represents a 28 percent premium for Agere shareholders. LSI fell $1.44, or 13.6 percent, to $9.12; Agere Systems rose $1.51, or 8.5 percent, to $19.30.

Financier Kirk Kerkorian’s investment arm, Tracinda Corp., on Monday launched a cash tender offer to acquire 15 million shares of casino operator MGM Mirage.

Tracinda currently holds a 55.9 percent stake in the Las Vegas-based company, whose shares rose $2.68, or 5 percent, to $56.35.

The Russell 2000 Index, which tracks smaller companies, was up 14.68, or 1.88 percent, at 795.85. The index is now at a closing high.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide